Malignant neoplasm of other and ill-defined sites

C3_OTHER_OR_ILLDEFINED_SITES

benign neoplasm: A neoplasm which is characterized by the absence of morphologic features associated with malignancy (severe cytologic atypia, tumor cell necrosis, and high mitotic rate). Benign neoplasms remain confined to the original site of growth and do not metastasize to other anatomic sites.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Cause of death: ICD-10 C76

Cause of death: ICD-9 195

Cause of death: ICD-8 195

Cancer registry: Topography ICD-O-3 C76

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions C.O.D: 10, 8, 9

Check minimum number of events None

Include endpoints None

C3_OTHER_OR_ILLDEFINED_SITES

Extra metadata

Level in the ICD hierarchy 3

First used in FinnGen datafreeze DF4

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of other and ill-defined sites based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	91	37	54
Unadjusted prevalence (%)	0.03	0.02	0.04
Mean age at first event (years)	64.96	68.29	62.68

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: C3_OTHER_OR_ILLDEFINED_SITES – Malignant neoplasm of other and ill-defined sites
GWS hits:

Survival analyses between endpoints

↥

Plot

before Malignant neoplasm of other and ill-defined sites
after Malignant neoplasm of other and ill-defined sites

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Malignant neoplasm of other and ill-defined sites

↥